1. Plasmodium cynomolgi: gametocytocidal activity of the anti-malarial compound CDRI 80/53 (elubaquine) in rhesus monkeys.
- Author
-
Puri SK and Dutta GP
- Subjects
- Animals, Anopheles parasitology, Antimalarials pharmacology, Disease Models, Animal, Dose-Response Relationship, Drug, Female, Insect Vectors parasitology, Macaca mulatta, Male, Primaquine pharmacology, Primaquine therapeutic use, Antimalarials therapeutic use, Malaria drug therapy, Plasmodium cynomolgi drug effects, Primaquine analogs & derivatives
- Abstract
The gametocytocidal action of a new enamine analogue of primaquine, elubaquine (compound CDRI 80/53, bulaquine), has been evaluated against Plasmodium cynomolgi B in rhesus monkeys. Colony bred Anopheles stephensi mosquitoes were fed on gametocyte carrying rhesus monkeys prior to and at varying intervals after oral administration of a single dose of elubaquine at doses ranging between 0.63 and 5.00 mg/kg. Complete loss of oocyst development and mosquito infectivity was observed within 24 h after administering a single 1.25 mg/kg dose, while higher dose of 3.75 mg/kg inhibited oocyst development within 5 h, indicating gametocytocidal action of the compound. Elubaquine did not show any action against developing oocysts in the vector.
- Published
- 2005
- Full Text
- View/download PDF